UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

Oncogene, 2012-03, Vol.31 (12), p.1558-1570

2012

Volltextzugriff (PDF)

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.2029-2036

2011

Volltextzugriff (PDF)

Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures

Lupus, 2019-11, Vol.28 (13), p.1524-1533

2019

Volltextzugriff (PDF)

Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis

Genes and immunity, 2012-04, Vol.13 (3), p.207-213

2012

Volltextzugriff (PDF)

High tumor mutational burden (TMB) and PD-L1 have similar predictive utility in 2L+ NSCLC patients (pts) treated with anti-PD-L1 and anti-CTLA-4

Annals of oncology, 2018-10, Vol.29, p.viii19-viii19

2018

Volltextzugriff (PDF)

Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A)

Annals of oncology, 2018-10, Vol.29, p.viii425-viii425

2018

Volltextzugriff (PDF)

AB0167 Pharmacokinetics of Sifalimumab and Target Modulation of a Type I Interferon Gene Signature in Patients with Moderate to Severe Systemic Lupus Erythematosus

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.946-946

2015

Volltextzugriff (PDF)

CD19-positive antibody-secreting cells provide immune memory

Blood advances, 2018-11, Vol.2 (22), p.3163-3176

2018

Volltextzugriff (PDF)

15LBA High tumoral IFNγ mRNA, PD-L1 protein, and combined IFNγ mRNA/PD-L1 protein expression associates with response to durvalumab (anti-PD-L1) monotherapy in NSCLC patients

European journal of cancer (1990), 2015-09, Vol.51, p.S717-S717

2015

Volltextzugriff (PDF)

THU0459 RNA Sequencing Reveals Over-Expression of IGG4 and IGE MRNAS and Activated TH2-Related, Treg-Related, and Other Cytokine Pathways in the Blood of IGG4-Related and Mikulicz's Disease Patients

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.342-342

2014

Volltextzugriff (PDF)

THU0034 CD19 Distinguishes Memory and Pre-Memory Antibody Secreting Cells

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A175-A175

2013

Volltextzugriff (PDF)

OP0238 Suppression of T Cell Activation and Collagen Accumulation by an Anti-Type I Interferon Receptor Monoclonal Antibody in Adult Subjects with Systemic Sclerosis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.152-152

2014

Volltextzugriff (PDF)

42 MEDI5117 Administration Confers Specific Inhibitions of IL-6 Related Growth Pathways in Tumor Xenograft Models

European journal of cancer (1990), 2012-11, Vol.48, p.15-15

2012

Volltextzugriff (PDF)

OP0255 Inhibition of the Plasma Cell Signature Correlates with Reduced Collagen Expression in Systemic Sclerosis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A139-A139

2013

Volltextzugriff (PDF)

SAT0020 Molecular characterization of collagen in muscle of polymyositis and dermatomyositis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.477-478

2013

Volltextzugriff (PDF)

SAT0004 Genomic signatures characterize leukocyte infiltration in myositis muscles

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.472-472

2013

Volltextzugriff (PDF)

THU0005 Investigating the Plasma Cell Signature in Autoimmune Disease

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A166-A166

2013

Volltextzugriff (PDF)

Preliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v492

2019

Volltextzugriff (PDF)

1203P - Preliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v492-v492

2019

Volltextzugriff (PDF)

Feasibility of a bilateral 4000-6000 Hz notch as a phenotype for genetic association analysis

International journal of audiology, 2015-10, Vol.54 (10), p.645-652

2015

Volltextzugriff (PDF)

Generation of a functional humanized Delta-like ligand 4 transgenic mouse model

Transgenic research, 2017-12, Vol.26 (6), p.791-798

2017

Volltextzugriff (PDF)

A Phase 1 first-in-human study of MEDI0680, an anti-PD-1 monoclonal antibody (mAb) in adult patients (pts) with advanced tumors

Annals of oncology, 2016-10, Vol.27, p.vi367-vi367

2016

Volltextzugriff (PDF)

Combating Human Trafficking: Policy Gaps and Hidden Political Agendas in the USA and Germany

Morehouse, Christal

2009 edition., 2009

Volltextzugriff (PDF)

Synthetic arabinofuranosyl oligosaccharides as Mycobacterial arabinosyltransferase substrates

Bioorganic & medicinal chemistry letters, 1998-03, Vol.8 (5), p.437-442

1998

Volltextzugriff (PDF)

Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis

International immunology, 2003-08, Vol.15 (8), p.915-925

2003

Volltextzugriff (PDF)

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(217)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures

Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis

High tumor mutational burden (TMB) and PD-L1 have similar predictive utility in 2L+ NSCLC patients (pts) treated with anti-PD-L1 and anti-CTLA-4

Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A)

AB0167 Pharmacokinetics of Sifalimumab and Target Modulation of a Type I Interferon Gene Signature in Patients with Moderate to Severe Systemic Lupus Erythematosus

CD19-positive antibody-secreting cells provide immune memory

15LBA High tumoral IFNγ mRNA, PD-L1 protein, and combined IFNγ mRNA/PD-L1 protein expression associates with response to durvalumab (anti-PD-L1) monotherapy in NSCLC patients

THU0459 RNA Sequencing Reveals Over-Expression of IGG4 and IGE MRNAS and Activated TH2-Related, Treg-Related, and Other Cytokine Pathways in the Blood of IGG4-Related and Mikulicz's Disease Patients

THU0034 CD19 Distinguishes Memory and Pre-Memory Antibody Secreting Cells

OP0238 Suppression of T Cell Activation and Collagen Accumulation by an Anti-Type I Interferon Receptor Monoclonal Antibody in Adult Subjects with Systemic Sclerosis

42 MEDI5117 Administration Confers Specific Inhibitions of IL-6 Related Growth Pathways in Tumor Xenograft Models

OP0255 Inhibition of the Plasma Cell Signature Correlates with Reduced Collagen Expression in Systemic Sclerosis

SAT0020 Molecular characterization of collagen in muscle of polymyositis and dermatomyositis

SAT0004 Genomic signatures characterize leukocyte infiltration in myositis muscles

THU0005 Investigating the Plasma Cell Signature in Autoimmune Disease

Preliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours

1203P - Preliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours

Feasibility of a bilateral 4000-6000 Hz notch as a phenotype for genetic association analysis

Generation of a functional humanized Delta-like ligand 4 transgenic mouse model

A Phase 1 first-in-human study of MEDI0680, an anti-PD-1 monoclonal antibody (mAb) in adult patients (pts) with advanced tumors

Combating Human Trafficking: Policy Gaps and Hidden Political Agendas in the USA and Germany

Synthetic arabinofuranosyl oligosaccharides as Mycobacterial arabinosyltransferase substrates

Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis

Suchergebnisse filtern